Free Trial

scPharmaceuticals (SCPH) News Today

scPharmaceuticals logo
$2.32 +0.02 (+0.87%)
Closing price 04:00 PM Eastern
Extended Trading
$2.32 0.00 (0.00%)
As of 06:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Craig-Hallum Sticks to Its Buy Rating for scPharmaceuticals (SCPH)
scPharmaceuticals Inc. stock logo
scPharmaceuticals (NASDAQ:SCPH) Given New $12.00 Price Target at Maxim Group
Maxim Group reduced their price target on scPharmaceuticals from $20.00 to $12.00 and set a "buy" rating for the company in a research report on Thursday.
scPharmaceuticals Inc. stock logo
HC Wainwright Reiterates "Buy" Rating for scPharmaceuticals (NASDAQ:SCPH)
HC Wainwright reiterated a "buy" rating and set a $18.00 target price on shares of scPharmaceuticals in a research note on Thursday.
scPharmaceuticals price target lowered to $12 from $20 at Maxim
scPharmaceuticals Inc. stock logo
scPharmaceuticals (NASDAQ:SCPH) Issues Earnings Results
scPharmaceuticals (NASDAQ:SCPH - Get Free Report) posted its quarterly earnings data on Wednesday. The company reported ($0.35) EPS for the quarter, beating the consensus estimate of ($0.39) by $0.04. scPharmaceuticals had a negative return on equity of 244.93% and a negative net margin of 264.60%.
scPharmaceuticals Inc. stock logo
scPharmaceuticals (NASDAQ:SCPH) Announces Quarterly Earnings Results
scPharmaceuticals (NASDAQ:SCPH - Get Free Report) announced its earnings results on Wednesday. The company reported ($0.35) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.39) by $0.04. scPharmaceuticals had a negative return on equity of 244.93% and a negative net margin of 264.60%.
Q4 2024 scPharmaceuticals Inc Earnings Call
scPharmaceuticals reports Q 4EPS (35c), consensus (39c)
scPharmaceuticals Inc. stock logo
King Luther Capital Management Corp Buys 632,120 Shares of scPharmaceuticals Inc. (NASDAQ:SCPH)
King Luther Capital Management Corp raised its stake in shares of scPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) by 28.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,857,910 share
TD Cowen Keeps Their Buy Rating on scPharmaceuticals (SCPH)
scPharmaceuticals Inc. stock logo
HC Wainwright Forecasts Lower Earnings for scPharmaceuticals
scPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) - Investment analysts at HC Wainwright dropped their FY2024 earnings per share estimates for shares of scPharmaceuticals in a report issued on Monday, March 3rd. HC Wainwright analyst D. Tsao now forecasts that the company will post earnings per
scPharmaceuticals Inc. stock logo
Brokers Set Expectations for SCPH FY2029 Earnings
scPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) - Stock analysts at HC Wainwright issued their FY2029 earnings per share estimates for scPharmaceuticals in a note issued to investors on Monday, March 3rd. HC Wainwright analyst D. Tsao expects that the company will earn $0.70 per share for the
scPharmaceuticals Inc. stock logo
scPharmaceuticals (SCPH) Projected to Post Quarterly Earnings on Wednesday
scPharmaceuticals (NASDAQ:SCPH) will be releasing earnings before the market opens on Wednesday, March 12, Financial Modeling Prep reports.
scPharmaceuticals Inc. stock logo
scPharmaceuticals (NASDAQ:SCPH) Earns "Buy" Rating from HC Wainwright
HC Wainwright reissued a "buy" rating and issued a $18.00 target price on shares of scPharmaceuticals in a report on Monday.
scPharmaceuticals Inc. stock logo
85,184 Shares in scPharmaceuticals Inc. (NASDAQ:SCPH) Bought by Johnson Financial Group LLC
Johnson Financial Group LLC purchased a new stake in shares of scPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 85,184 shares of the company's stock, valued at appro
scPharmaceuticals Inc. stock logo
Rice Hall James & Associates LLC Has $3.50 Million Stock Position in scPharmaceuticals Inc. (NASDAQ:SCPH)
Rice Hall James & Associates LLC lifted its holdings in shares of scPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) by 59.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 989,635 shares of the company's stock after purchasing an
Centessa Pharmaceuticals (CNTA) Initiated with a Buy at TD Cowen
TD Cowen Sticks to Its Buy Rating for scPharmaceuticals (SCPH)
Craig-Hallum Issues a Buy Rating on scPharmaceuticals (SCPH)
scPharmaceuticals Inc. stock logo
Suvretta Capital Management LLC Purchases New Position in scPharmaceuticals Inc. (NASDAQ:SCPH)
Suvretta Capital Management LLC acquired a new position in shares of scPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 2,049,009 shares of the company's
scPharmaceuticals Inc. stock logo
scPharmaceuticals Inc. (NASDAQ:SCPH) Shares Bought by Rubric Capital Management LP
Rubric Capital Management LP lifted its position in shares of scPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) by 35.5% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 4,775,000 shares of the company's stock after buying an add
scPharmaceuticals Inc. stock logo
HC Wainwright Has Bearish Estimate for SCPH FY2024 Earnings
scPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) - Investment analysts at HC Wainwright reduced their FY2024 earnings per share (EPS) estimates for shares of scPharmaceuticals in a note issued to investors on Thursday, November 14th. HC Wainwright analyst D. Tsao now expects that the company wi
scPharmaceuticals price target lowered to $12 from $16 at Craig-Hallum
scPharmaceuticals's Earnings Outlook
scPharmaceuticals Inc. stock logo
scPharmaceuticals (SCPH) Set to Announce Earnings on Wednesday
scPharmaceuticals (NASDAQ:SCPH) will be releasing earnings after the market closes on Wednesday, November 13, Zacks reports.
Remove Ads
Get scPharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for SCPH and its competitors with MarketBeat's FREE daily newsletter.

SCPH Media Mentions By Week

SCPH Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SCPH
News Sentiment

0.00

0.62

Average
Medical
News Sentiment

SCPH News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SCPH Articles
This Week

0

2

SCPH Articles
Average Week

Remove Ads
Get scPharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for SCPH and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:SCPH) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners